The document provides an overview of selling strategies for third party controls. It discusses opportunities in molecular labs for controls that test the entire diagnostic process. Products like Amplichek for CT/GC testing are highlighted as lucrative. The document also reviews Bio-Rad's expanded product line for coagulation/hematology labs and how to position these controls by emphasizing benefits like menu breadth, stability, and helping with CLIA compliance. The sales strategy involves targeting top accounts in these areas and leveraging tools like the QC OnCall program.
